Medicamen Organics share price

  • NaN%Low risk
  • NaN%Moderate risk
  • NaN%Balanced risk
  • NaN%High risk
  • NaN%Extreme risk
  • 47.85(1.92%)
    June 17, 2025 11:14:33 AM IST
    • NSE
    • BSE
  • Vol : 4.00K (NSE + BSE)
    Last 20 day avg : 16.30 K

Medicamen Organics is trading 1.92% upper at Rs 47.85 as compared to its last closing price. Medicamen Organics has been trading in the price range of 47.85 & 47.85. Medicamen Organics has given -12.89% in this year & 10.21% in the last 5 days. Medicamen Organics has TTM P/E ratio 5.91 as compared to the sector P/E of 23.93.Listed peers of Medicamen Organics include Rulka Electricals (4.98%), Kalana Ispat (-2.67%), Medicamen Organics (1.92%).The Mutual Fund holding in Medicamen Organics was at -% in . The MF holding has - from the last quarter. The FII holding in Medicamen Organics was at 0.07% in 31 Mar 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Key Metrics

Updated on Jun 17, 2025, 09:56 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.82
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    12.83
    Higher than historical values
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.41
    Higher than industry
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
47.85
Highest
47.85
52 week range
Lowest
19.60
Highest
159.40
Medicamen Organics Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    No Data
    Financial insights for Medicamen Organics are currently unavailable
    Please check back later.
Medicamen Organics Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 44.18
  • R2
  • 49.72
  • R3
  • 52.48
Pivot41.42
  • S1
  • 35.88
  • S2
  • 33.12
  • S3
  • 27.58
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Medicamen Organics Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Rulka Electricals
Moderately Bearish
143.304.9861.0223.811.62-0.56
Kalana Ispat
Moderately Bearish
42.00-2.6754.7636.621.27-0.86
Medicamen Organics
Bullish
47.851.9255.9812.581.79-0.52
Neelam Linens And Garments India
Bearish
25.600.3951.7621.782.28-167.71
Kontor Space
Moderately Bullish
86.852.0053.6712.521.97-15.84
Medicamen Organics Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Medicamen Organics is currently unavailable
    Please check back later.
    Shareholding Insights
    No Data
    Shareholding insights for Medicamen Organics are currently unavailable
    Please check back later.
    Medicamen Organics Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-29Audited Results
    2025-01-08To consider Fund Raising
    2024-11-14Quarterly Results & Others
    About the company Medicamen Organics
    • Industry
    • ISININE0PE401018
    • BSE Code
    • NSE CodeMEDIORG
    Medicamen Organics Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and distribution of a range of pharmaceutical dosages, including generic dosage in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspension, and dry powders for governments (including both state and central governments) and private institutions as contract manufacturer/third party manufacturer. Its product portfolio consists of over 84 products and comprises a range of drugs such as antibacterial, anti-diarrheal, antifungal, anti-malarial, anti-diabetic, proton pump inhibitor, antihistamine, antihypertensive drugs, anti-lipidemic drug, antiparasitic, multivitamin, multimineral and non-steroidal anti-inflammatory drug (NSAIDS). Its products are marketed across India as well as African, CIS and southeast Asian Countries, such as Congo, Benin, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan, and Kenya.
    • Management Info
    • Bal GuptaExecutive Chairman of the Board, Managing Director
    • Lalit GuptaChief Financial Officer
    • Varsha BansalCompliance Officer, Company Secretary
    • Shailesh GaurExecutive Director
    • Ashutosh GuptaWhole Time Director
    Medicamen Organics Share Price FAQs

    Medicamen Organics is trading at 47.85 as on Tue Jun 17 2025 05:44:33. This is 1.92% upper as compared to its previous closing price of 46.95.

    The market capitalization of Medicamen Organics is 55.98 Cr as on Tue Jun 17 2025 05:44:33.

    The 52 wk high for Medicamen Organics is 159.40 whereas the 52 wk low is 19.60

    Medicamen Organics can be analyzed on the following key metrics -

    • TTM P/E: 5.91
    • Sector P/E: 23.93
    • Dividend Yield: 0.00%
    • D/E ratio: -

    Medicamen Organics reported a net profit of 4.05 Cr in 2025.